Welcome to our dedicated page for TILRAY BRANDS news (Ticker: TLRY), a resource for investors and traders seeking the latest updates and insights on TILRAY BRANDS stock.
TIlray Brands, Inc. (TLRY) generates frequent news as a global lifestyle and consumer packaged goods company active across cannabis, beverage, wellness, and entertainment categories. Company updates often highlight developments in its cannabis brands, medical cannabis operations, beverage portfolio, and strategic corporate actions, giving investors and followers insight into how Tilray is executing its multi-category strategy.
News coverage commonly includes financial results and segment performance across cannabis, beverage, wellness, and distribution, as reflected in Tilray’s quarterly earnings releases. These updates may discuss trends in international medical cannabis revenue, Canadian adult-use cannabis sales, and distribution activity through Tilray Pharma. Corporate announcements, such as the implementation of a one-for-ten reverse stock split and related shareholder decisions, are also reported through press releases and SEC filings.
Tilray’s brand and product news provides detail on new launches and category expansion. Recent communications feature Dry January and holiday guides showcasing hemp-derived THC beverages, zero-proof spirits, non-alcoholic beers, and craft beers, as well as cannabis-infused beverages under brands like Mollo and XMG. Other releases focus on innovations in cannabis vapes and concentrates under brands such as Good Supply and Redecan, and curated cannabis gift guides that reflect consumer trends in Canada.
Regulatory and medical developments are another important theme. Tilray Medical has issued statements on U.S. federal cannabis rescheduling and the creation of Tilray Medical USA, outlining a framework for U.S. medical cannabis expansion based on experience in regulated international markets. For readers tracking TLRY, this news stream offers context on how the company responds to policy changes, evolves its brand portfolio, and communicates with shareholders. Bookmark this page to access an organized feed of Tilray’s earnings releases, product announcements, regulatory updates, and other material company news.
Breckenridge Distillery, a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), has announced its newest Broncos Bourbon Blends and Breckenridge Broncos Vodka as the official Bourbon and Vodka of the Denver Broncos. The -edition bourbons, available in Colorado retailers starting next week, pay tribute to the Broncos' 2024 Mile High Collection.
Two teams, led by Broncos legends Randy Gradishar and Ed McCaffrey, created unique blends: the Broncos Blue Blend and the Broncos Orange Blend. Both are 87 proof (43.5% ABV), honoring McCaffrey's jersey number. Fans can vote for their favorite blend and enter to win tickets to a Broncos game by participating in social media contests.
Shock Top, a subsidiary of Tilray Brands (NASDAQ: TLRY), announces the return of its seasonal brew, Shock Top Twisted Pretzel, after a three-year hiatus. The Belgian-style wheat beer is enhanced with the flavors of a fresh-baked pretzel, making it a unique autumn offering. Available in 6-packs and 12-packs, as well as on draft at select locations, it will be sold through November. To celebrate, Shock Top is hosting a sweepstakes where one winner and a friend will get a four-day trip to Munich's Oktoberfest.
Breckenridge Brewery, a renowned Colorado craft brewer, is opening a new location in Fort Collins in early August 2024. The 10,000-square-foot facility will feature a full-service restaurant and brewery, employing 40 staff members including head brewer Ryan Joy. To celebrate, Breckenridge is hosting a First Pour Party on August 17th, 2024, featuring live music, local vendors, and raffles. The event will showcase a commemorative beer and crowler, with proceeds benefiting Project C.U.R.E. The new location aims to blend Breckenridge's legacy with innovative brewing and community collaboration, offering an elevated dining experience alongside their craft beers.
Tilray Brands reported strong financial results for fiscal 2024, with a 26% increase in net revenue to $789 million. Key highlights include:
- Cannabis net revenue grew 24% to $273 million
- Beverage-alcohol net revenue surged 113% to $202 million
- Reduced net convertible debt by ~$300 million
- Achieved positive adjusted free cash flow of $6.6 million
- Completed strategic acquisitions of eight craft beer brands, HEXO Corp, and Truss Beverage Co
The company's diversification strategy has positioned it as a leader in cannabis, beverages, and wellness across multiple regions. Tilray is now the 5th largest craft brewer in the U.S. and holds the #1 recreational cannabis market share in Canada.
Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY) announced that its subsidiary Aphria RX GmbH has received a trading license in Germany. This license allows Aphria RX to sell and distribute a wide range of medical cannabis products to pharmacies, hospitals, and medical wholesalers throughout Germany. The development significantly expands Tilray's commercial growth opportunities in the German market.
With both cannabis cultivation and trade licenses, Tilray is now well-positioned to capitalize on the growing market opportunity in Germany. This further strengthens Tilray's position as a global leader in cannabis research, cultivation, production, and distribution. The company remains committed to advocating for responsible cannabis regulations, education, research, and accessibility to high-quality medical cannabis.
Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY) has achieved another milestone in European medical cannabis. The company received approval for its second medical cannabis extract in Portugal, Tilray Oral Solution THC10:CBD10. This follows the earlier approvals of Tilray Medical whole flower THC 18 and the first cannabis extract in Portugal.
Denise Faltischek, Chief Strategy Officer and Head of International at Tilray Brands, emphasized the significance of this approval in expanding medical cannabis offerings for Portuguese patients. The company views this as a important step in meeting patient care needs and providing high-quality cannabis products for specific medical conditions.
Tilray Medical operates in over 20 countries, offering a diverse portfolio of EU-GMP certified medicinal cannabis products. The company remains committed to supporting global medical cannabis patient care through quality products accessible via healthcare practitioners.
Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY) has announced that its German subsidiary, Aphria RX GmbH, has received the first new cannabis cultivation license under Germany's new Cannabis Act (MedCanG). This license allows Aphria RX to increase production by approximately 5 times and introduce new strains, enhancing patient access across Germany.
Key points:
- Aphria RX can now cultivate and manufacture a broader range of medical cannabis
- The facility can expand from 3 to 31 approved strains
- Aphria RX was designed with guidance from Kevin Anderson of Broken Coast Cannabis
- The new license positions Tilray to capitalize on Germany's growing medical cannabis market
This development is expected to significantly improve access to high-quality, German-produced medical cannabis for patients nationwide.
SweetWater Brewing Company, a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), has launched Rowdy Peach IPA in collaboration with Atlanta United FC. This new brew, with 6.8% ABV, celebrates the team's passionate fans and soccer culture. The IPA features juicy peach aromas and comes in red and black cans, inspired by the team's colors and supporter chant.
Rowdy Peach IPA is available at Atlanta United home matches, SweetWater's taproom, in six-packs, and on draft. As the team's official craft beer partner, SweetWater is enhancing the gameday experience with tailgate activations and watch parties. The partnership aims to deepen connections with the Atlanta community and soccer fans nationwide.
Manitoba Harvest, a subsidiary of Tilray Brands (NASDAQ: TLRY; TSX: TLRY), has introduced new Coffee and Chocolate flavors to its Organic Bioactive Fiber supplement line, developed in partnership with Brightseed®. These products aim to enhance gut wellness and healthy digestion, offering 7g of fiber per serving for the Chocolate flavor and 6g of fiber with 60mg of caffeine for the Coffee variant.
The supplements utilize upcycled hemp hulls containing unique bioactives to support gut health. New research published in the Journal of Dietary Supplements highlights the potential of hemp hulls and Bio Gut Fiber to enhance gut health, including support for healthy gut barrier function and metabolic wellbeing. A pre-clinical study also confirmed the prebiotic activity of Brightseed® Bio Gut Fiber.
The new products are available for $19.99 on manitobaharvest.com and select US retailers, with Amazon availability coming soon.
Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods company, has announced the release date for its fourth quarter and full fiscal year 2024 financial results. The results will be disclosed on July 29, 2024, after market close.
Following the release, Tilray will host a live audio webcast at 4:30 pm Eastern Time to discuss the results. Investors can access the webcast through the Investors section of Tilray's website. Additionally, stockholders can submit and upvote questions via the Say Technologies platform until July 26, 2024, for the upcoming Q&A session.
FAQ
What is the current stock price of TILRAY BRANDS (TLRY)?
What is the market cap of TILRAY BRANDS (TLRY)?
